The disease can be hard to detect after it spreads. But MSK oncologist Michael Morris helped develop a new tool just approved by the FDA that finds the cancer.
This new technology can also be used to treat advanced prostate cancer in patients like Michael Rosenblum (above) and has just been designated a breakthrough therapy by the FDA.
